Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Current report_201_buy back_espi.pdf Treasury shares

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 201 / 2023
Date of issue: 2023-12-04
Short name of the issuer
SOPHARMA AD
Subject
Treasury shares
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Sofia, Bulgaria, December 4, 2023 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on December 1, 2023 the Company bought 66 000 own shares representing 0.0382% of the share capital of the Company, at a total value of BGN 469 600 on the Bulgarian Stock Exchange, the average price per share was BGN 7,12.
Annexes
File Description
Current report_201_buy back_espi.pdf
Current report_201_buy back_espi.pdf		 Treasury shares

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2023-12-04 Ognian Donev Executive Director
20231204_140225_1714857330_Current_report_201_buy_back_espi.pdf

Pobierz